223 related articles for article (PubMed ID: 23515638)
1. A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes.
Liu Y; Yang Y; Zhang C
Int J Nanomedicine; 2013; 8():1083-93. PubMed ID: 23515638
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
3. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.
Yan C; Wu Y; Feng J; Chen W; Liu X; Hao P; Yang R; Zhang J; Lin B; Xu Y; Liu R
Int J Nanomedicine; 2013; 8():245-55. PubMed ID: 23345972
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
Debergh I; Van Damme N; De Naeyer D; Smeets P; Demetter P; Robert P; Carme S; Pattyn P; Ceelen W
Ann Surg Oncol; 2014 Jun; 21(6):2097-104. PubMed ID: 24356800
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.
Cui Y; Zhang C; Luo R; Liu H; Zhang Z; Xu T; Zhang Y; Wang D
Int J Nanomedicine; 2016; 11():5671-5682. PubMed ID: 27895477
[TBL] [Abstract][Full Text] [Related]
6. Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
Liu C; Liu DB; Long GX; Wang JF; Mei Q; Hu GY; Qiu H; Hu GQ
Chin Med J (Engl); 2013 Jun; 126(12):2242-7. PubMed ID: 23786932
[TBL] [Abstract][Full Text] [Related]
7. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
8. Multimodality tumor imaging targeting integrin alphavbeta3.
Cai W; Sam Gambhir S; Chen X
Biotechniques; 2005 Dec; 39(6 Suppl):S14-25. PubMed ID: 20158499
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
10. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
Zhang C; Liu H; Cui Y; Li X; Zhang Z; Zhang Y; Wang D
Int J Nanomedicine; 2016; 11():1097-108. PubMed ID: 27051285
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
13. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.
Sipkins DA; Cheresh DA; Kazemi MR; Nevin LM; Bednarski MD; Li KC
Nat Med; 1998 May; 4(5):623-6. PubMed ID: 9585240
[TBL] [Abstract][Full Text] [Related]
14. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
15. Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner.
Jiang T; Zhang C; Zheng X; Xu X; Xie X; Liu H; Liu S
Int J Nanomedicine; 2009; 4():241-9. PubMed ID: 20011241
[TBL] [Abstract][Full Text] [Related]
16. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression.
Dijkgraaf I; Beer AJ; Wester HJ
Front Biosci (Landmark Ed); 2009 Jan; 14(3):887-99. PubMed ID: 19273106
[TBL] [Abstract][Full Text] [Related]
17. Imaging of integrin alphavbeta3 expression.
Beer AJ; Schwaiger M
Cancer Metastasis Rev; 2008 Dec; 27(4):631-44. PubMed ID: 18523730
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Zhang C; Jugold M; Woenne EC; Lammers T; Morgenstern B; Mueller MM; Zentgraf H; Bock M; Eisenhut M; Semmler W; Kiessling F
Cancer Res; 2007 Feb; 67(4):1555-62. PubMed ID: 17308094
[TBL] [Abstract][Full Text] [Related]
19. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
